The evaluation of SHOX2 methylation in EBUS-TBNA samples combined with the sex and age from the patient, and the diameter and SUV of the lymphadenopathy, increases the accuracy of EBUS-TBNA for the diagnosis of metastatic node involvement in NSCLC. This evidence concerns the gene SHOX2 and non-small cell lung carcinoma.